Rhesus TGFBR2 Protein (Fc Tag)
TGFBR2
- 100ug (NPP2951) Please inquiry
Catalog Number | P90063-C02H |
---|---|
Organism Species | Rhesus |
Host | Human Cells |
Synonyms | TGFBR2 |
Molecular Weight | The recombinant rhesus TGFBR2 comprises 377 amino acids and has a calculated molecular mass of 42.4 KDa. |
predicted N | Ile 24 |
SDS-PAGE | |
Purity | > 95 % as determined by SDS-PAGE |
Protein Construction | A DNA sequence encoding the rhesus TGFBR2 (NP_001248080.1) (Met1-Arg159) was expressed with the Fc region of human IgG1 at the C-terminus. |
Bio-activity | 1. Measured by its binding ability in a functional ELISA. 2. Immobilized Rhesus TGFB1-His (P90294-C08H) at 10 μg/mL (100 μL/well) can bind Rhesus TGFBR2-Fc. The EC50 of Rhesus TGFBR2-Fc is 28-56 ng/mL. |
Research Area | Cardiovascular |Angiogenesis |Growth Factor & Receptor |Transforming Growth Factor Beta (TGF-beta) Superfamily |TGF-beta Superfamily Receptors |
Formulation | Lyophilized from sterile PBS, pH 7.4 1. Normally 5 % - 8 % trehalose, mannitol and 0.01% Tween80 are added as protectants before lyophilization. Specific concentrations are included in the hardcopy of COA. |
Background | TGFBR2 is member of the Ser/Thr protein kinase family and the TGFB receptor subfamily. It is a transmembrane protein. TGFBR2 is comprised by a C-terminal protein kinase domain and an N-terminal ectodomain. The ectodomain consists of a compact fold containing nine beta-strands and a single helix stabilised by a network of six intra strand disulphide bonds. The folding topology includes a central five-stranded antiparallel beta-sheet, eight-residues long at its centre, covered by a second layer consisting of two segments of two-stranded antiparallel beta-sheets. TGFBR2 has a protein kinase domain, forms a heterodimeric complex with another receptor protein, and binds TGF-beta. This receptor/ligand complex phosphorylates proteins, which then enter the nucleus and regulate the transcription of a subset of genes related to cell proliferation. Mutations in TGFBR2 gene have been associated with Marfan syndrome, Loeys-Deitz Aortic Aneurysm Syndrome, and the development of various types of tumors. TGFBR2 attenuates the biological activities of TGF-beta in colorectal cancer. TGFBR2 expression is increased in oral squamous cell carcinoma cells. Its expression is decreased by IL-1beta while inducing Sp3 via NFkappaB. TGFB2 and TGFBR2 are involved in the antiestrogenic activity. |
Reference |